Related Experiment Videos
HBs antigen and blood glucose concentration
Medecine Interne
|January 1, 1980
Summary
High blood glucose levels correlate with the absence of Hepatitis B surface antigen (HBsAg) in patients with liver cirrhosis and diabetes. This suggests hyperglycemia may inhibit Hepatitis B virus replication or HBsAg expression.
Area of Science:
- Hepatology
- Virology
- Endocrinology
Background:
- Hepatitis B virus (HBV) infection is a major cause of liver disease.
- The presence of Hepatitis B surface antigen (HBsAg) is a key indicator of HBV infection.
- The relationship between metabolic factors like hyperglycemia and HBV infection markers is not fully understood.
Purpose of the Study:
- To investigate the correlation between high blood glucose levels and the presence or absence of HBsAg.
- To explore the potential impact of hyperglycemia on HBV infection markers in patients with liver cirrhosis and diabetes mellitus.
Main Methods:
- Counterelectrophoresis (CEP) was used to detect HBsAg presence.
- HBsAg status was analyzed in 76 liver cirrhosis patients and 431 diabetes mellitus patients.
- Blood glucose levels (glycemia) were measured and compared between HBsAg-positive and HBsAg-negative groups.
Main Results:
- A significant correlation was observed between high blood glucose levels and HBsAg absence.
- HBsAg-negative cirrhotic patients exhibited significantly higher glycemia (95.75 +/- 6.36 ng/100 ml) than HBsAg-positive patients (78.30 +/- 10.2/100 ml).
- HBsAg absence was noted in all but one diabetic patient, with a very low incidence (0.2%) compared to general and non-hepatic disease populations.
Conclusions:
- Sustained high blood glucose concentrations appear to be a primary factor responsible for HBsAg negativity.
- Hyperglycemia may directly impede HBV replication or indirectly affect HBsAg secretion/excretion through metabolic hepatic dysfunction.
- The inhibitory effect of high glucose concentrations might explain failures in HBV culture experiments.